Transgene’s (Paris:TNG) shareholders held their Combined General Meeting (ordinary and extraordinary) today, chaired by Philippe Archinard, Chairman and CEO, to approve the company financial statements for the year ended December 31, 2018 and to vote on the other resolutions submitted to their approval.
May 22, 2019
· 1 min read